Live Breaking News & Updates on Macmillan Foundation

Stay updated with breaking news from Macmillan foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neoadjuvant nivolumab improves long-term survival for lung cancer

Analysis of a Phase II trial for non-small cell lung cancer has suggested neoadjuvant nivolumab improved five-year recurrence-free survival. ....

United States , Samuel Rosner , Patrick Forde , Bristol Myers Squibb , National Institutes Of Health , Johns Hopkins University Cancer Center , Drug Administration , Cancer Foundation , Lung Cancer Foundation Of America , Cancer Research Group , Macmillan Foundation , Lungevity Foundation , International Immuno , Oncology Network , Thoracic Oncology Clinical Research Program , Memorial Sloan Kettering Cancer Center , Clinical Cancer Research , Associate Professor , Sidney Kimmel Comprehensive Cancer Center , Johns Hopkins , Stand Up To Cancer , International Immuno Oncology Network , International Association , Lung Cancer , Prevent Cancer Foundation , Lung Cancer Foundation ,

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes. ....

United States , Samuel Rosner , Patrick Forde , Bristol Myers Squibb , Emily Henderson , Cancer Research Industry , National Institutes Of Health , Johns Hopkins University Cancer Center , Cancer Foundation , Lung Cancer Foundation Of America , Cancer Research Group , Cancer Research , Macmillan Foundation , Lungevity Foundation , American Association For Cancer Research , Thoracic Oncology Clinical Research Program , International Immuno , Oncology Network , Memorial Sloan Kettering Cancer Center , Clinical Cancer Research , American Association , Sidney Kimmel Comprehensive Cancer Center , Johns Hopkins , Research Industry Focus , Drug Administration , Stand Up To Cancer ,